Abstract
The structure and integrity of the ageing brain is interchangeably linked to physical health, and cardiometabolic risk factors (CMRs) are associated with dementia and other brain disorders. In this mixed cross-sectional and longitudinal study (interval mean and standard deviation = 19.7 ± 0.5 months), including 1062 datasets from 790 healthy individuals (mean (range) age = 46.7 (18-94) years, 54% women), we investigated CMRs and health indicators including anthropometric measures, lifestyle factors, and blood biomarkers in relation to brain structure using MRI-based morphometry and diffusion tensor imaging (DTI). We performed tissue specific brain age prediction using machine learning and performed Bayesian multilevel modelling to assess changes in each CMR over time, their respective association with brain age gap (BAG), and their interaction effects with time and age on the tissue-specific BAGs. The results showed credible associations between DTI-based BAG and blood levels of phosphate and mean cell volume (MCV), and between T1-based BAG and systolic blood pressure, smoking, pulse, and C-reactive protein (CRP), indicating older-appearing brains in people with higher cardiometabolic risk (smoking, higher blood pressure and pulse, low-grade inflammation). Longitudinal evidence supported interactions between both BAGs and waist-to-hip ratio (WHR), and between DTI-based BAG and systolic blood pressure and smoking, indicating accelerated ageing in people with higher cardiometabolic risk (smoking, higher blood pressure, and WHR). The results demonstrate that cardiometabolic risk factors are associated with brain ageing. While randomised controlled trials are needed to establish causality, our results indicate that public health initiatives and treatment strategies targeting modifiable cardiometabolic risk factors may also improve risk trajectories and delay brain ageing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study is supported by the Research Council of Norway (223273, 249795, 248238, 276082), the South Eastern Norway Regional Health Authority (2014097, 2015044, 2015073, 2016083, 2018037, 2018076), the Norwegian ExtraFoundation for Health and Rehabilitation (2015/FO5146), KG Jebsen Stiftelsen, Swiss National Science Foundation (grant PZ00P3 193658), German Federal Ministry of Education and Research (BMBF, grant 01ZX1904A), ERA-Net Cofund through the ERA PerMed project IMPLEMENT (Research Council of Norway 298646), and the European Research Council under the European Union's Horizon 2020 Research and Innovation program (ERC StG, Grant # 802998 and RIA Grant # 847776).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
1. The study was conducted in line with the Declaration of Helsinki and the Regional Ethics Committee for Medical and Health Research Ethics (REC); South East division in Norway. 2. The Regional Committee for Medical and Health Research Ethics (REC) has reviewed and approved the Research Project. StrokeMRI study reference number: 2014/694, TOP study reference number: 2009/2485.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data and code will be openly accessible on Open Science Framework.(https://osf.io/7z6cv/)
